Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Its also approved for children aged 12 and older with obesity and a weight of over 60 kg (~132 lb)
These effects are dose-dependent and align with its unique receptor pharmacology and optimized pharmacokinetics
Bypasses Part D Red Tape: Because the program runs through a central CMS processor, your individual Part D plan cannot deny your coverage or force you through restrictive "step therapy" for obesity medications
Additional observations suggest that it may influence cardiac electrical stability and thrombotic processes in preclinical studies
US$ 24.24
US$ 20.40
US$ 24.74
